Sen. John Hoeven (R-ND) bought $50K-$100K of ABBV stock

John Hoeven, U.S. Senator (R-ND), disclosed a purchase of AbbVie Inc. (NYSE) (ABBV) stock worth $50K-$100K in a STOCK Act filing on Apr 23, 2014.

The trade happened on Mar 31, 2014, 23 days before it was made public.

ABBV has moved +472.9% since the trade date, from $51.40 to $294.45 (Nov 12, 2026 close).